Optimization of Diarylthiazole B‐Raf Inhibitors: Identification of a Compound Endowed with High Oral Antitumor Activity, Mitigated hERG Inhibition, and Low Paradoxical EffectMaurizio Pulici, Marina Ciomei, Fabio Gasparri et al.|ChemMedChem|2014Cited by 9
Abstract 5163: Characterization of NMS-E194, a selective and potent PERK inhibitor with efficacy in the KMS-11 multiple myelomaClaudia Perrera, Barbara Valsasina, Maurizio Pulici et al.|Cancer Research|2017Cited by 1
Abstract 2522: Identification and characterization of new highly selective and potent BRAF inhibitorsMaurizio Pulici, Marina Ciomei, Nadia Amboldi et al.|Cancer Research|2010Cited by 0
Abstract 3754: Characterization of NMS-P285, a new highly selective and potent BRAF inhibitorMaurizio Pulici, Marina Ciomei, Nadia Amboldi et al.|Cancer Research|2012Cited by 0
B-Raf Kinase V600E mutant in complex with a diarylthiazole B-Raf InhibitorElena Casale, Marina Ciomei, Marina Fasolini et al.|Unknown|2014Cited by 0